Take a look below for this year's takes
www.cedargroveresearch.com/p/our-6-inve...
The timing couldn't have been more perfect. We talked
➡️ The issues with their GRAIL test
➡️ The dark side of lab tests and telehealth in general
➡️ The SNAC patent (perfectly timed)
➡️ And much more
The timing couldn't have been more perfect. We talked
➡️ The issues with their GRAIL test
➡️ The dark side of lab tests and telehealth in general
➡️ The SNAC patent (perfectly timed)
➡️ And much more
Once garbage, always garbage.
Once garbage, always garbage.
The company has a stellar, de-risked drug asset, and we think the downside is limited.
See why we're optimistic below
www.cedargroveresearch.com/p/special-si...
The company has a stellar, de-risked drug asset, and we think the downside is limited.
See why we're optimistic below
www.cedargroveresearch.com/p/special-si...
Perfect timing, too, because we go into
➡️ GRAIL cancer screening
➡️ Telehealth's future
➡️ The dark side of telehealth
➡️ #$HIMS treatment offerings
www.cedargroveresearch.com/p/ic-9-talki...
Perfect timing, too, because we go into
➡️ GRAIL cancer screening
➡️ Telehealth's future
➡️ The dark side of telehealth
➡️ #$HIMS treatment offerings
www.cedargroveresearch.com/p/ic-9-talki...
An email from a sub the other day, which I greatly appreciate.
#$LQDA we pitched in Jan'25 and it's already ~4x
www.cedargroveresearch.com
An email from a sub the other day, which I greatly appreciate.
#$LQDA we pitched in Jan'25 and it's already ~4x
www.cedargroveresearch.com
This year had way more shorts because we thought the coming landscape was more of a target-rich environment.
So far, from 12.22.25 to the close of business Friday, they've killed it.
This year had way more shorts because we thought the coming landscape was more of a target-rich environment.
So far, from 12.22.25 to the close of business Friday, they've killed it.
Good article from @WSJ about the intricacies of the new SNAP program and why it's causing chaos.
As a reminder, we wrote about this over a week ago about companies who have higher exposure to these changes that could face headwinds.
Good article from @WSJ about the intricacies of the new SNAP program and why it's causing chaos.
As a reminder, we wrote about this over a week ago about companies who have higher exposure to these changes that could face headwinds.
"Studies show that after stopping the drugs, people typically regain lost weight within about 1.5 years. And any improvements in blood sugar, blood pressure or cholesterol are reversed."
"Studies show that after stopping the drugs, people typically regain lost weight within about 1.5 years. And any improvements in blood sugar, blood pressure or cholesterol are reversed."
The best part, there's still juice left! WHP is launching a tender offer that could still yield great returns.
www.cedargroveresearch.com/p/quick-upda...
The best part, there's still juice left! WHP is launching a tender offer that could still yield great returns.
www.cedargroveresearch.com/p/quick-upda...
Highlighted back in September that #$LE could be taken private from WHP.
This morning, #$LE announced it was being acquired. The stock is up ~26% right now
www.cedargroveresearch.com/p/arb-update...
Highlighted back in September that #$LE could be taken private from WHP.
This morning, #$LE announced it was being acquired. The stock is up ~26% right now
www.cedargroveresearch.com/p/arb-update...
They're effectively locking themselves out by doing that. Why be bullish if they do that?
These SNAP changes will affect millions of Americans and restrict certain food/bev categories from being purchased.
1/2
www.cedargroveresearch.com/p/big-change...
These SNAP changes will affect millions of Americans and restrict certain food/bev categories from being purchased.
1/2
www.cedargroveresearch.com/p/big-change...
Negative implications from the OBBBA that partially took effect on Jan 1 and will ramp up over 2026
A few companies we discuss could have sizable exposure
Get it via the 🔗 below
www.cedargroveresearch.com
Negative implications from the OBBBA that partially took effect on Jan 1 and will ramp up over 2026
A few companies we discuss could have sizable exposure
Get it via the 🔗 below
www.cedargroveresearch.com
1. God do they know how screwed they are going into midterms
2. We're going to see a hell of a lot more "the boat is sinking, what else can we throw overboard to keep us afloat" over the next few months
1. God do they know how screwed they are going into midterms
2. We're going to see a hell of a lot more "the boat is sinking, what else can we throw overboard to keep us afloat" over the next few months
Indicies up but so much over the past week has gotten shot in the face despite the bulk of earnings season having yet to start
Don't know what to make of it
Indicies up but so much over the past week has gotten shot in the face despite the bulk of earnings season having yet to start
Don't know what to make of it
At that rate, the U.S. would be 3.1x China & Russia combined.
www.cedargroveresearch.com/p/cotw-how-a...
At that rate, the U.S. would be 3.1x China & Russia combined.
www.cedargroveresearch.com/p/cotw-how-a...
New products unlikely to offset lower core. $HIMS relied too much on GLP-1s to get them to the next leg up and now competition is fiercer than ever w/ still no access to $NVO oral pill
Lower PT from $32 to $29 on higher multiple
New products unlikely to offset lower core. $HIMS relied too much on GLP-1s to get them to the next leg up and now competition is fiercer than ever w/ still no access to $NVO oral pill
Lower PT from $32 to $29 on higher multiple